Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
---|
08/05/2004 | WO2004065422A2 Cancerous disease modifying antibodies |
08/05/2004 | WO2004065407A2 Improved gastrin releasing peptide compounds |
08/05/2004 | WO2004064870A2 Radiolabelled tissue factor binding agent and the use thereof |
08/05/2004 | WO2004064869A2 Amyloid-binding, metal-chelating agents |
08/05/2004 | WO2004064788A2 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
08/05/2004 | WO2004064760A2 Aptamer therapeutics useful in ocular pharmacotherapy |
08/05/2004 | WO2003074450A3 Radiolabeled selective androgen receptor modulators and their use in prostate cancer imaging and therapy |
08/05/2004 | US20040152157 G-protein coupled receptors |
08/05/2004 | US20040152144 Novel method of diagnosing, monitoring, staging, imaging and treating breast cancer |
08/05/2004 | US20040151665 Scrrening; separation using cancer cell cytotoxicity; diagnosis, antitumor agents, anticancer agents; administering monoclonal antibodies |
08/05/2004 | CA2514200A1 Amyloid-binding, metal-chelating agents |
08/05/2004 | CA2513772A1 Cancerous disease modifying antibodies |
08/05/2004 | CA2513331A1 Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus |
08/05/2004 | CA2513308A1 Pancreatic cancer associated antigen, antibody thereto, and diagnostic and treatment methods |
08/05/2004 | CA2513044A1 Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
08/05/2004 | CA2513004A1 Aptamer therapeutics useful in ocular pharmacotherapy |
08/05/2004 | CA2512482A1 Improved gastrin releasing peptide compounds |
08/04/2004 | EP1442751A1 Method of imaging |
08/04/2004 | EP1441773A1 Pacap compositions and methods for tumor imaging and therapy |
08/04/2004 | EP1192131B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using isoindoline derivatives |
08/04/2004 | EP1150658B1 Method for controlling liposome size |
08/04/2004 | EP1028781A4 $i(IN SITU)-GENERATED SOLID RADIATION SOURCE BASED ON TUNGSTEN?188 /RHENIUM?188 AND THE USE THEREOF |
08/03/2004 | US6770621 Polyacid glycopeptide derivatives |
08/03/2004 | US6770259 Simultaneous dual isotope imaging of cardiac perfusion and cardiac inflammation |
08/03/2004 | US6770020 Neutron capture therapy (nct) using gadolinium diethylenetriaminepentaacetic acid; treating glioblastomas, gliomas |
08/03/2004 | US6770019 Radiation source for endovascular radiation treatment in form of a wire |
07/29/2004 | WO2004062722A2 Prevention of systemic toxicity during radioimmunotherapy for intravascularly disseminated cancers |
07/29/2004 | WO2004062574A2 Improved linkers for radiopharmaceutical compounds |
07/29/2004 | WO2004062568A2 Conjugate of losartan, valsartan, candesartan or eprosartan and a chelant as contrast agent |
07/29/2004 | WO2004041296A3 Pharmaceutical composition comprising a tissue factor antagonist and protein c polypeptides |
07/29/2004 | WO2004035536A3 Azo compounds for type i phototherapy |
07/29/2004 | WO2004021996A3 Backbone-substituted bifunctional dota ligands, complexes and compositions thereof, and methods of using same |
07/29/2004 | US20040146516 Lumen-exposed molecules and methods for targeted delivery |
07/28/2004 | EP1439854A2 Conformationally constrained parathyroid hormone (pth) analogs |
07/28/2004 | CN1159071C Preparation method of biodegradable medicine composite macromolecular scaffold material |
07/27/2004 | US6767711 Antibody, its binding portion or a probe is capable of binding to normal, benign, hyperplastic and cancerous epithelia cells and killing or ablating them; does not recognize antigens circulating in the blood |
07/27/2004 | US6767704 Methods of screening and diagnosing esophageal cancer by determining guanylin cyclase C expression |
07/27/2004 | US6767531 High dose radionuclide complexes for bone marrow suppression |
07/27/2004 | US6767319 Delivery methods, systems and components for use with hazardous pharmaceutical substances |
07/22/2004 | WO2004061423A2 Compositions and methods for diagnosing and treating colon cancers |
07/22/2004 | WO2004060409A1 Enhanced scintigraphic imaging agents for imaging of infection and inflammation |
07/22/2004 | WO2004060317A2 Combination of gallium compounds with nonchemotherapeutic anticancer agents in the treatment of neoplasia |
07/22/2004 | WO2004021977A3 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer |
07/22/2004 | WO2003101919A3 Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same |
07/22/2004 | US20040143099 for treatment or prevention of a thrombotic or coagulopathic disease, respiratory or inflammatory disease |
07/22/2004 | US20040142872 Polyamine modified antibodies having specific binding affinity for A beta also have increased permeability at the blood-brain barrier and can be used for passive immunization and treatment of Altzheimer's disease |
07/22/2004 | US20040141999 Antiviral and antiretroviral radioimmunomedicaments based on (alpha)-emitters and (beta)-emitters |
07/22/2004 | US20040141979 isolation and production of cancerous disease modifying antibodies (CDMAB) and to the use of these CDMAB in therapeutic and diagnostic processes; anticancer agents |
07/22/2004 | US20040141974 use of the protein BCMP 7, compositions comprising the protein, including vaccines, and antibodies that are immunospecific for the protein, in the diagnosis, prophylaxis and treatment of cancer |
07/22/2004 | US20040141922 Ultrasound contrast agents |
07/22/2004 | US20040141918 Nucleotide and deduced amino acid sequences of tumor gene Int6 |
07/22/2004 | US20040141916 Prevention of systemic toxicity during radioimmunotherapy for intravascularly disseminated cancers |
07/22/2004 | US20040141913 Cancerous disease modifying antibodies |
07/22/2004 | US20040141912 Administering medicinally-useful agent which is phospholipid scramblase (PLS)-dependent transported compound to cells, thereby causing selective transport of agent into cells |
07/22/2004 | CA2511907A1 Compositions and methods for diagnosing and treating colon cancers |
07/21/2004 | EP1438974A2 pH-sensitive liposomes based on diacyl-glycero-phosphoethanolamine and diacyl-succinyl-glycerol |
07/21/2004 | EP1438299A1 Bifunctional chelating agent for actinium |
07/21/2004 | EP1438076A1 Radiopharmaceutical agent for the treatment of early stage cancer |
07/21/2004 | EP1289571B1 Prochelators of radiometal labeled molecules |
07/21/2004 | EP1274465B1 Use of bile acid derivatives conjugated with metal ion chelated complexes for the diagnostic assessment of microvascular permeability |
07/21/2004 | EP0959904B1 Hybrid compositions for intracellular targeting |
07/20/2004 | US6765104 Transition metal complexes of n, n',n″trialkyl-cis-1,3,5-triaminocyclohexane and related compositions and methods of synthesis and use |
07/15/2004 | WO2004058302A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
07/15/2004 | WO2004058298A1 Immunotherapy of b cell malignancies and autoimmune disease using unconjugated antibodies and conjugated antibodies, antibody combinations and fusion proteins |
07/15/2004 | WO2004032708A3 Vasoregulating compounds and methods of their use |
07/15/2004 | WO2003100033A3 ANTI-αvβ6 ANTIBODIES |
07/15/2004 | US20040138233 Novel urokinase inhibitors |
07/15/2004 | US20040136998 Methods and compositions for treating or preventing insulin-related disorders using binding agents specific for prostate specific membrane antigen |
07/15/2004 | US20040136993 inducing an immunogenic response against alpha-SN |
07/15/2004 | US20040136908 Anti-cd19 immunotoxins |
07/15/2004 | US20040136907 Compounds with binding affinity for both alpha v beta 3 and somatostatin receptors; arginine, glycine, aspartic acid; improved overall affinity for tumors |
07/15/2004 | US20040136906 Radiodiagnostic imaging or radiotherapy polypeptides consisting of a moiety capable of complexing a medically useful metal ion or radionuclide (metal chelator) attached to a GRP receptor targeting peptide by a linker or spacer group |
07/15/2004 | US20040136905 Magnetically guided particles for radiative therapies |
07/15/2004 | US20040136904 Dry powder compositions comprising labelled particles for inhalation |
07/15/2004 | CA2512188A1 Immunotherapy of b cell malignancies and autoimmune disease using unconjugated antibodies and conjugated antibodies, antibody combinations and fusion proteins |
07/15/2004 | CA2509510A1 Method of using a cox-2 inhibitor and a topoisomerase ii inhibitor as a combination therapy in the treatment of neoplasia |
07/14/2004 | EP1437146A1 Measurement of liquid phase gastric emptying |
07/14/2004 | EP1437145A1 Enhanced scintigraphic imaging agents for imaging of infection and inflammation |
07/14/2004 | EP1436429A2 Targeted nucleic acid constructs and uses related thereto |
07/14/2004 | EP1436294A1 Tetracyclic azaindoles and -indolines having serotonin 5-ht2c activity |
07/14/2004 | EP1435973A1 Coadministration of transport protein with conjugated cobalamin to deliver agents |
07/14/2004 | EP1435826A2 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
07/14/2004 | EP1177009A4 Methods for forming a radioactive stent |
07/14/2004 | CN1157225C Lectin compositions and uses tehreof |
07/13/2004 | CA2202913C Antibody reagent for detecting dissecting aortic aneurysm and uses thereof |
07/13/2004 | CA2131528C Methods and compositions for targeting the vasculature of solid tumors |
07/13/2004 | CA2047699C Expanded porphyrins: large prophyrin-like tripyrroledimethine-derived macrocycles |
07/08/2004 | WO2004056858A2 Methods and agents for diagnosis and prevention, amelioration or treatment of goblet cell-related disorders |
07/08/2004 | WO2004056725A1 Solid-phase preparation of 18f-labelled amino acids |
07/08/2004 | WO2004056400A1 Solid-phase fluorination of uracil and cytosine |
07/08/2004 | WO2004056399A2 Solid-phase fluorination of benzothiazoles |
07/08/2004 | WO2004056398A1 Isotope labeled camptothecin derivatives |
07/08/2004 | WO2004035744A3 Methods for purifying radiolabelled compounds |
07/08/2004 | WO2004035022A3 Prepolymeric materials for site specific delivery to the body |
07/08/2004 | WO2004029024A3 Radiolabeled neurokinin-1 receptor antagonists |
07/08/2004 | WO2003077871A3 Method of diagnosis and treatment of breast lesions |
07/08/2004 | US20040132643 Histone deacelylase inhibitors in diagnosis and treatment of thyroid neoplasms |
07/08/2004 | US20040132137 Thyroid glycoprotein horomone for treatment and prevention of hyperthyroidism and graves' disease |
07/08/2004 | US20040131555 Mixture of tobramycin in carrier; aerosols; respiratory system disorders |
07/08/2004 | US20040131550 Bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands |